Stem Cell Therapeutics Corp. (TSX-V: SSS) is the only public Canadian company developing stem cell therapeutic technologies through partnerships with academic and research institutions across Canada and abroad. We intend to use our extensive expertise and experience in the stem cell arena with knowledge of the biotechnology sector and capital markets to both develop our existing pipeline of valuable intellectual property in regenerative medicine and also to expand the Company’s interests by acquiring new early-stage clinical or late-stage developmental candidates initially in Canada and internationally.